Ward, Simon ![]() ![]() |
Official URL: http://dx.doi.org/10.1021/jm100679e
Abstract
A novel series of AMPAR positive modulators is described that were identified by high throughput screening. The molecules of the series have been optimized from a high quality starting point hit to afford excellent developability, tolerability, and efficacy profiles, leading to identification of a clinical candidate. Unusually for an ion channel target, this optimization was integrated with regular generation of ligand-bound crystal structures and uncovered a novel chemotype with a unique and highly conserved mode of interaction via a trifluoromethyl group.
Item Type: | Article |
---|---|
Date Type: | Publication |
Status: | Published |
Schools: | Medicine |
ISSN: | 0022-2623 |
Last Modified: | 23 Oct 2022 12:59 |
URI: | https://orca.cardiff.ac.uk/id/eprint/109336 |
Citation Data
Cited 59 times in Scopus. View in Scopus. Powered By Scopus® Data
Actions (repository staff only)
![]() |
Edit Item |